Riskpilot← Back to searchSign inGet full accessMaren Tandvård AB
ABActiveOrg 5569075186Järnagatan 3Dental practice care activities · NACE 8623Est. 20123 employees
Revenue 2024
SEK 4,9M
-10% vs 2023
EBITDA margin
18.4%
-16% vs 2023
Equity ratio
87.6%
Financial strength
Net profit 2024
SEK 627K
-12% vs 2023
| Revenue | SEK 4,9M | -10% |
| EBITDA | SEK 898K | -16% |
| Net profit | SEK 627K | -12% |
| Total assets | SEK 4,1M | -5% |
| Equity | SEK 3,6M | +0% |
| Employees | 3 | — |
Legal name
Maren Tandvård AB
Org number
5569075186
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
22 oktober 2012
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva tandvård.
Address
Järnagatan 3
Email
daniel-ercan@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 838 | 4 766 | 5 250 | 5 416 | 4 880 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 322 | 1 127 | 1 085 | 1 068 | 898 |
| Depreciation & amort. | −128 | −233 | −204 | −161 | −147 |
| EBIT | 1 194 | 894 | 881 | 907 | 751 |
| Net financials | −6 | −10 | −14 | 20 | 48 |
| Profit before tax | 1 187 | 884 | 868 | 926 | 799 |
| Tax | −274 | −193 | −198 | −213 | −172 |
| Net profit | 913 | 691 | 670 | 713 | 627 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 899 | 3 926 | 3 906 | 4 340 | 4 123 |
| Equity | 3 304 | 3 375 | 3 455 | 3 603 | 3 610 |
| Long-term debt | 126 | 276 | 244 | 204 | 173 |
| Short-term debt | 469 | 275 | 207 | 534 | 340 |
| Total debt | 595 | 551 | 451 | 738 | 513 |
EBITDA margin
18.4%
This company
15.8%
Market median
+16% vs market
20202024
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
20202024
Return on equity
17.4%
This company
18.4%
Market median
+5% vs market
20202024
Net profit margin
12.8%
This company
8.1%
Market median
+58% vs market
20202024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SJ | Audit | 2022 |
DE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Maren Tandvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan John Paul Rosberg | Audit | 0 companies |
| Daniel Ercan | Chief Executive Officer | 0 companies |
| Gabriella Angelica Önder | Deputy Board Member | 0 companies |
| Albert Ercan | Deputy Board Member | 0 companies |